Telangana Govt To Crack Down On Fake Medicine Manufacturers

Hyderabad: Health Minister Damodar Rajanarsimha said on Monday that the government had taken steps to crack down on the fake medicine manufacturers with an iron fist.

On Monday, the Health Minister distributed appointment letters to 17 drug inspectors, with five individuals assigned to Zone 1 and 12 to Zone 2 selected through merit by the Telangana Public Service Commission.

The newly selected 17 drug inspectors have been directed to work for the strengthening of the department. Speaking on the occasion, Rajanarsimha said that new drug inspectors have been appointed for continuous monitoring to prevent counterfeit drugs. The Minister directed the candidates who received the appointment letters to carry out the job duties for the benefit of society with great responsibility.

The State Family Welfare Commissioner, Drug Control Administration, Director General (Incharge) RV Karnan, and Joint Director Ram Dan participated in this programme.

Related Posts

  • Pharma
  • July 11, 2025
  • 43 views
India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

July:  India’s Glenmark Pharmaceuticals (GLEN.NS), opens new tab said on Thursday its innovation arm, Ichnos Glenmark Innovation (IGI), and AbbVie (ABBV.N), opens new tab have signed an exclusive licensing agreement…

  • Pharma
  • July 10, 2025
  • 128 views
Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

India stands tall as a pharmaceutical powerhouse, supplying 20% of the world’s generic medicines and nearly 62% of global vaccines. Yet, this success now faces a storm: US President Donald…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Novartis wins approval for first malaria drug for newborns and babies

Novartis wins approval for first malaria drug for newborns and babies

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning